Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey.
Valerie Bonnelle, Will J Smith, Natasha L. Mason, Mauro Cavarra, Pamela Kryskow, Kim Pc Kuypers, Johannes G. Ramaekers, Amanda Feilding
Br J Pain July 14, 2022 DOI: 10.1177/20494637221114962 (opens in new tab) via PubMed Central
Summary
AI-generated from the abstractA survey of chronic pain sufferers who have used classical psychedelics reports that both macrodoses and microdoses are associated with pain relief. Among respondents, 78% reported pain reduction after macrodosing, and 55% reported pain reduction after microdosing. The findings suggest that psychedelics may have analgesic potential in this population, though the survey design cannot establish causation.
Study at a glance
| Characteristics | Population survey Peer reviewed |
|---|---|
| Population | Chronic pain sufferers who have used classical psychedelics |
| Intervention | classical psychedelics |
| Keywords | Psychedelics: classical psychedelics Hallucinogens Entheogens Psychotropics Chronic pain sufferers |
| Citations | 26 |
| Key finding | Both macrodoses and microdoses of classical psychedelics are associated with pain reduction in chronic pain sufferers, with 78% reporting relief after macrodosing and 55% after microdosing. |
Abstract
Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey.